
Rehuman Pharmaceuticals Private Limited
About Rehuman Pharmaceuticals Private Limited
Data last updated:
Rehuman Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 27 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2020PTC126219. Its GSTIN is 09AAKCR0489B1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vijay Kumar Pandey (Managing Director) and Pooja Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 5 G – 18 Sector – G Lda Colony Kp Road, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2025, the company reported a revenue of ₹1 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹15,294 (net margin 0.2%) and EBITDA of ₹20,668 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Company details
Contact details
Rehuman Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressShop No – 5 G – 18 Sector – G Lda Colony Kp Road, Lucknow, Uttar Pradesh, India – 226012
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Rehuman Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rehuman Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rehuman Pharmaceuticals Private Limited, buy the company report.
Financials of Rehuman Pharmaceuticals Private Limited
FY 2025 filings availableRehuman Pharmaceuticals Private Limited reported revenue of ₹1 Cr (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,668 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,294 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rehuman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rehuman Pharmaceuticals Private Limited
Rehuman Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Tiwari | Director | 27 Jan 2020 | 6 Years 9 Months | Current |
| Vijay Kumar Pandey Also directs: Klenviz Pharmaceuticals Private Limited | Managing Director | 20 Jan 2026 | 0 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Rehuman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rehuman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rehuman Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCR0489B1ZA | Uttar Pradesh | Active | 21 Feb 2020 |
To see the full GST registrations and return filing status of Rehuman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rehuman Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Vijay Kumar Pandey was appointed as Managing Director on 20 Jan 2026.
Frequently asked questions
Rehuman Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 27 January 2020 (6+ years old) and is registered under CIN U24304UP2020PTC126219.
Rehuman Pharmaceuticals has 2 current directors:
- Vijay Kumar Pandey - Managing Director
- Pooja Tiwari - Director
The latest financial statements of Rehuman Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Rehuman Pharmaceuticals is 09AAKCR0489B1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rehuman Pharmaceuticals is U24304UP2020PTC126219. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rehuman Pharmaceuticals was incorporated on 27 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
Vijay Kumar Pandey was appointed as Managing Director on 20 Jan 2026. Vijay Kumar Pandey ceased to be Managing Director on 28 Feb 2022. Vishwanath Tiwari was appointed as Director on 28 Feb 2022. Rehuman Pharmaceuticals has 4 board changes on record in total.
The registered office of Rehuman Pharmaceuticals is at Shop No – 5 G – 18 Sector – G Lda Colony Kp Road, Lucknow, Uttar Pradesh, India – 226012.
Rehuman Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Rehuman Pharmaceuticals can be reached at its registered office: Shop No – 5 G – 18 Sector – G Lda Colony Kp Road, Lucknow, Uttar Pradesh, India – 226012.

